EXAS vs SLVM · rev $2.76B vs P/E 15, rev $1.56B
EXACT Sciences Corporation (EXAS) versus Sylvamo Corp (SLVM) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Sylvamo Corp (SLVM) is a paper & paper products company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SLVM revenue for 2026-06-30 was $1.56B. Net income was -$14.0M. SLVM currently screens at market cap $1.54B and trailing P/E 15.4.
EXAS currently screens at market cap $20.03B. SLVM currently screens at market cap $1.54B and trailing P/E 15.4.
Not investment advice. Open the EXAS and SLVM stock pages for the full models.
Not investment advice.